Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Maintains Outperform on Lattice Semiconductor, Raises Price Target to $100

Baird analyst Tristan Gerra maintains Lattice Semiconductor (NASDAQ:LSCC) with a Outperform and raises the price target from $75 to $100.

byBenzinga Newsdesk

February 22, 2023

1 minute read

Baird analyst Tristan Gerra maintains Lattice Semiconductor (NASDAQ:LSCC) with a Outperform and raises the price target from $75 to $100.

Epizyme + 20 Stocks Moving In Monday’s Pre-Market Session

By Lisa Levin

Today, 5:32 PM

Gainers Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday.

AGTC

Morgan Stanley Maintains Overweight on DTE Energy, Raises Price Target to $123

By Benzinga Newsdesk

Today, 5:32 PM

Morgan Stanley analyst Stephen Byrd maintains DTE Energy (NYSE:DTE) with a Overweight and raises the price target from $115 to $123.

DTE

Stocks That Hit 52-Week Highs On Thursday

By Benzinga Insights

Today, 5:32 PM

On Thursday, 5 companies set new 52-week highs.

EPAY

Adagene Inks Third Cancer Trial Collaboration With Merck

By Vandana Singh

Today, 5:32 PM

Adagene Inc (NASDAQ:ADAG) has entered into a third clinical trial collaboration and supply agreement with Merck & Co Inc (NYSE:MRK). The agreement includes…

ADAG

Baird Maintains Outperform on Lattice Semiconductor, Raises Price Target to $100

Related Posts

Epizyme + 20 Stocks Moving In Monday’s Pre-Market Session

Morgan Stanley Maintains Overweight on DTE Energy, Raises Price Target to $123

Stocks That Hit 52-Week Highs On Thursday

Adagene Inks Third Cancer Trial Collaboration With Merck